Publication dates

Heart Failure Industry, January 2015 Market Reports from Top Publishers

You might be interested in: medical equipment, chronic heart failure, therapeutics, telemedicine, angina, angina pectoris, cardiology, hospital, medical center, neurology, sleep apnea, stem cell, stent.


 
1-10 of 97 reports for Heart Failure

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • Jan 2015
  • by Firstword Pharma

... Indeed, the chronic heart failure agent is believed to represent both a significant growth driver for novartis as well as, alongside the pcsk9 class of dyslipidaemia products, among the first in a new wave of medicines ...

Global Congestive Heart Failure Drugs Market 2015-2019

Global Congestive Heart Failure Drugs Market 2015-2019

  • $ 3 000
  • Industry report
  • January 2015
  • by Infiniti Research Limited

... Congestive heart failure drugs market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of approved drugs and generics used in the treatment ...

ARCA biopharma, Inc. (Symbol:ABIO) SWOT Analysis, Strategy, Revenues and Profits

ARCA biopharma, Inc. (Symbol:ABIO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Tm, is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for the prevention of atrial fibrillation in patients with heart failure. The company offers products and services ...

China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review

China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... And hydrochlorothiazide, and astragalus polysaccharide for injection. It offers products for depression and anxiety, infectious diseases, treatment of acute decompensated heart failure, treatment of adult and children ...

GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Horlicks, and medicines. Gsk offers pharmaceutical products for the treatment of asthma, malaria, depression, migraine, diabetes, heart failure, digestive conditions, and cancer; and vaccines to protect ...

RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review

RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... For the treatment of hypertension and congestive heart failure; rhb-102 (bekinda), a proprietary, once-daily, extended-release and oral formulation of the antiemetic drug ondansetron in phase iii clinical trials ...

Amarantus Bioscience Holdings, Inc. (AMBS) - Financial and Strategic SWOT Analysis Review

Amarantus Bioscience Holdings, Inc. (AMBS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Such as parkinson's disease, als and alzheimer's disease, and cardiovascular diseases including myocardial infarction, coronary artery disease and heart failure. The company holds license to eltoprazine, owns ...

Cardio3 BioSciences SA (CARD) - Financial and Strategic SWOT Analysis Review

Cardio3 BioSciences SA (CARD) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Product portfolio includes c-cure, c3bs-gqr-1, c3bs-gqr-4, c3bs-pqr-1, and c-cathez. Cardio3 biosciences products find application in the treatment of diseases such as cardiovascular diseases, heart failure ...

Ascenion GmbH - Product Pipeline Analysis, 2014 Update

Ascenion GmbH - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

... Lncrna lipcar - heart failure 64lncrna lipcar - heart failure product overview 64metabolomics assay - ovarian endometriosis 65metabolomics assay - ovarian endometriosis product overview 65 ...

Cardio3 BioSciences SA (CARD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cardio3 BioSciences SA (CARD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... heart failure, and acute myocardial infarction. The company has academic and industrial collaborations with mayo clinic, cardiovascular centre aalst, atmi and creganna contract design services. It also ...

About 2 500 reports for Heart Failure

Download Unlimited Documents from Trusted Public Sources

Hospital Industry in the US

  • September 2013
    89 pages
  • Hospital  

    Pneumonia  

    Heart Failure  

  • United States  

    North America  

View report >

3 Companies for Heart Failure

Read our Company Profiles

Bayer AG

Germany

Select Products Inc.

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.